Drugs in Context Health Economics & Outcomes Research welcomes a broad range of article types including original research, study protocols and review articles.
In line with the principle of providing context for healthcare professionals (HCPs) to properly inform and improve disease management in real world medicine, we especially encourage the submission of articles that provide context for trials of drug interventions in order to motivate improvements in disease management by HCPs practising medicine in the front line.
Review
This articles aims is to provide useful information and insights for the management of opioid agonist therapy by providing an overview that ranges from the characteristics of opioid use disorder patients to the macroscopic phenomena of social-health significance on a national scale, with a particular focus on the Italian territory.
Review
This article aimed to assess the prevalence of individuals with one or more risk factors for severe COVID-19 along with contraindications and potential drug–drug interactions due to ritonavir-containing COVID-19 therapy.
Commentary
This article discusses a workshop held at the 18th Annual Conference of the Pharmaceutical Contract Management Group (PCMG) in Krakow on 9th September 2022, which asked over 200 delegates what the clinical trial landscape would look like in 2050.
Original Research
This article reports findings on consumption behaviour, reason for intake and frequency of intake as well as consumer experience, satisfaction and characteristics of Supradyn Recharge or Supradyn Magnesium+Potassium.
Commentary
This article aims to provide contextual information for a general audience interested in conducting or evaluating cost-of-illness studies that may include drug costs and to describe key factors to consider when reviewing drug costs in the peer-reviewed literature.
